Riad Mishlawi, CEO
Watch Khalid Nabilsi, CFO
Watch Mazen Darwazah, Executive Vice Chairman and President of MENA
Watch Dr Bill Larkins, President Injectables
Watch Brian Hoffmann, President Generics
Said Darwazah, Executive Chairman and CEO
Khalid Nabilsi, CFO
Said Darwazah, Executive Chairman and CEO
Watch Khalid Nabilsi, CFO
Riad Mishlawi, President Injectables
Watch Mazen Darwazah, Executive Vice Chairman and President of MENA
Watch Brian Hoffmann, President Generics
Said Darwazah, Executive Chairman and CEO
Watch Khalid Nabilsi, CFO
Riad Mishlawi, President Injectables
Watch Brian Hoffmann, President Generics
Watch Mazen Darwazah, Executive Vice Chairman and President of MENA
Newsroom
All news stories Latest news
Featured
Hikma delivers strong 2023 performance and a positive outlook for 2024
Press Release, Financial Results 22 February 2024
- Hikma launches Foscarnet Sodium Injection, in the US Press Release, Product 23 September 2024 Hikma launches Foscarnet Sodium Injection, in the US
- Hikma completes Xellia acquisition Press Release, Corporate 10 September 2024 Hikma completes Xellia acquisition
- Hikma launches Clindamycin in 5% Dextrose Injection in the US Press Release, Product 03 September 2024 Hikma launches Clindamycin in 5% Dextrose Injection in the US
- Hikma Pharmaceuticals participates in naloxone training event with U.S. Congressman Buddy Carter ahead of National Fentanyl Awareness and Prevention Day Press Release, Product 20 August 2024 Hikma Pharmaceuticals participates in naloxone training event with U.S. Congressman Buddy Carter ahead of National Fentanyl Awareness and Prevention Day
Related content